Talphera (TLPH) Gains from Investment Securities (2010 - 2026)
Talphera (TLPH) recorded quarterly Gains from Investment Securities of -$1.2 million in Q1 2026, down 146.85% quarter-over-quarter from $2.6 million in Q4 2025, and down 168.75% on a YoY basis from $1.8 million in Q1 2025.
Talphera (TLPH) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Talphera's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 168.75% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$1.2 million (down 166.78% YoY), while the FY2025 annual figure was $2.6 million, up 6242.88% from the prior year.
- Gains from Investment Securities was -$1.2 million for Q1 2026 at Talphera, down from $2.6 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $15.6 million in Q1 2022 to a low of -$1.2 million in Q1 2026.
- Historically, Gains from Investment Securities has averaged $2.4 million across 5 years, with a median of $733308.0 in 2022.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities soared 31122.65% in 2025, then sank 168.75% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at $42000.0 in 2022, then plunged by 152.38% to -$22000.0 in 2023, then surged by 287.07% to $41156.0 in 2024, then soared by 6242.88% to $2.6 million in 2025, then sank by 146.85% to -$1.2 million in 2026.
- The last three Gains from Investment Securities figures came in at -$1.2 million (Q1 2026), $2.6 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Talphera | 56.51 Mn | 56.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 727,800.00 |
| Jun 30, 2025 | 727,800.00 |
| Mar 31, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 41,156.00 |
| Dec 31, 2024 | 41,156.00 |
| Sep 30, 2024 | 1.88 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 2,331.00 |
| Jun 30, 2024 | 2,331.00 |
| Mar 31, 2024 | 790,348.00 |
| Mar 31, 2024 | 790,348.00 |
| Dec 31, 2023 | -22,000.00 |
| Dec 31, 2023 | -22,000.00 |